Vitasoy International (0345) H2 2017 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2017 earnings summary
23 Oct, 2026Executive summary
FY2017 net sales fell 3% to HKD 5.4bn after the VUSA divestiture; excluding the divestiture, sales grew 6% and operating profit rose 3%.
Underlying profit attributable to shareholders grew 2%, with management citing operating profit improvement and lower net finance costs; brand and geographic expansion remained investment priorities.
Financial highlights
Gross profit rose 2% to HKD 2.9bn; gross margin expanded 2 percentage points to 53%, supported by manufacturing efficiency, volume and favorable milk powder and soybean costs.
EBITDA rose 33% to HKD 1.083bn; excluding the VUSA divestiture impact, EBITDA increased 6%.
Profit before tax rose 41% to HKD 844m; excluding the divestiture impact, it increased 3%.
Profit attributable to shareholders increased 16% to HKD 618m; excluding the divestiture gain, it grew 2%. Basic EPS rose 16% to HKD 0.589, or 1% excluding the gain.
Divestiture of the North American mainstream and SAN SUI businesses generated $51.4m consideration and a pre-tax gain of about $24.4m.
Outlook and guidance
FY2017-18 priorities include continued investment in brand equity and geographic expansion, with higher A&P and digital media activity in China and continued brand-building investment overall.
Raw material costs were turning from favorable to unfavorable, with some prices rising; this could pressure profitability as investment continues.
Vitasoy began selling products to trade in the Philippines following its JV with Universal Robina Corporation; further updates were planned for the November mid-year announcement.
Latest events from Vitasoy International
- Turnover rose 9%, while rising costs and a challenging FY2013/14 outlook tempered growth.0345
H2 2013 - FX-adjusted growth continued, led by China, while Australian drought pressures persist into H2.0345
H1 2020 - Disruptions cut FY profit, while market-share gains and gradual recovery underpin the outlook.0345
H2 2020 - FY18 sales rose 21%, led by China; FY19 growth is expected to moderate.0345
H2 2018 - Growth accelerated, but investment and tougher markets shifted focus to sustainable expansion.0345
H2 2016 - Profit rose 18% on asset disposal gain despite 3% revenue drop, with higher dividend and share buy-back.0345
H2 2026 - Revenue down 6% but profit, margins, and dividend held steady amid market challenges.0345
H1 2026 - Operating profit surged 50% and interim dividend rose to HK4.0 cents per share.0345
H1 2025 - FY24 profit surged as Mainland China and Hong Kong led recovery; Australia supply issues persisted.0345
H2 2024